Skip to main content Skip to navigation

News


MicrobeMeter Pro reaches prototype milestone

Humane Technologies Limited (HTL) has announced that it has successfully developed a prototype for the next generation of its microbial growth measurement device, the MicrobeMeter.


Freezing cells made safer thanks to new polymer

A new cryoprotectant polymer that dramatically improves the freezing of cells, has been discovered by researchers at the University of Warwick. The new polymers can reduce the amount of organic solvent required in cryopreservation (freezing cells) as well as giving more and healthier cells after thawing. Findings may help reduce cost and improve distribution of cells for cell-based therapies, diagnostics and research

Mon 05 Aug 2019, 09:51 | Tags: Chemistry, Life Sciences and Biotechnology, medical

Major Investment for Medherant

Medherant Limited, the clinical-stage developer of innovative transdermal delivery products for pain and CNS diseases using its unique TEPI Patch® technology, has today announced a new £2 million investment from Mercia Technologies PLC.

Wed 22 May 2019, 09:14 | Tags: Warwick Ventures, Life Sciences and Biotechnology, spinout

Base4 Innovation Ltd. closes £5 million ($6.5 million) funding round

Founded in 2007 with support from Warwick Ventures and the University of Warwick, Base4 has just closed a £5 million funding round, the company's largest to date. The funds will be used to expand the current team and increase lab space, facilitating the continued fast-paced development and automation of its technology.

Wed 22 Nov 2017, 15:08 | Tags: Warwick Ventures, Life Sciences and Biotechnology

VirionHealth Raises Series A Funding from Abingworth

virionhealth_signing.jpgVirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has raised up to £13 million in Series A funding from Abingworth, the international investment group dedicated to life sciences.

VirionHealth is a University of Warwick spinout company, set up with the support of Warwick Ventures, in 2017. Dr Laura Lane, Business Development Manager at Warwick Ventures, worked closely with Professors Nigel Dimmock and Andrew Easton to build a commercial team and secure the largest single investment into a Warwick spinout.

Warwick Ventures also helped secure translational funding from the Wellcome Trust, maintained the patents and developed the business plan that led to the investment by Abingworth.

Thu 12 Oct 2017, 13:27 | Tags: Warwick Ventures, Life Sciences and Biotechnology

Head of Life Sciences shortlisted for BBSRC Innovation Award

Congratulations to Professor Laura Green, Head of the School of Life Sciences at the University of Warwick, who has been shortlisted for an Innovator of the Year award from the Biotechnology and Biological Sciences Research Council (BBSRC).

Warwick Ventures has supported the translation of Professor Green's research, which focuses on reducing lameness in sheep flocks. The award winners will be announced on 24 May 2017.

Thu 18 May 2017, 13:47 | Tags: Life Sciences and Biotechnology

University of Warwick recognised by Bill Gates for work to combat neglected tropical diseases

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, has recognised the work being done by the University of Warwick to combat neglected tropical diseases (NTDs) in a speech at the Geneva Summit on NTDs.

 

Wed 26 Apr 2017, 15:12 | Tags: Warwick Ventures, Life Sciences and Biotechnology

In search of the stroke detector

Warwick neuroscientist Professor Nick Dale talks to the Observer about the SMARTChip stroke diagnostic tool he developed, and about Sarissa Biomedical, the spin out company set up by Warwick Ventures to commercialise the technology.

Mon 23 Jan 2017, 10:12 | Tags: Warwick Ventures, Life Sciences and Biotechnology

University of Warwick spinout Medherant receives £1.5m

Medherant news imageMedherant, a spinout from the University of Warwick, has received £1.5m in funding from Mercia Technologies and a set of undisclosed new investors.

Mercia Technologies announcement

Article in TechCityNews

Wed 28 Sep 2016, 09:59 | Tags: Life Sciences and Biotechnology

BioTuesday in Warwick - A Digital Success

OBN’s latest BioTuesday Event, the first ever in the Midlands, was held at the Institute of Digital Healthcare at Warwick University. Driving Innovation and Collaboration in Digital Health was the hot topic of the night covered in detail by a panel of experts.

Thu 28 Jul 2016, 14:05 | Tags: Life Sciences and Biotechnology

Older news